Back
Trevi Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
TRVI
Trevi Therapeutics
Last Price:
$6.85
Seasonality Move:
-28.76%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRVI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Trevi Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.23 | Buy |
20-day SMA: | 6.01 | Buy |
50-day SMA: | 6.28 | Buy |
200-day SMA: | 4.73 | Buy |
8-day EMA: | 4.67 | Buy |
20-day EMA: | 2.54 | Buy |
50-day EMA: | 1.16 | Buy |
200-day EMA: | 0.31 | Buy |
Trevi Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.62 | Buy |
Relative Strength Index (14 RSI): | 68.07 | Buy |
Chaikin Money Flow: | 1580985 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.7 - 6.5) | Buy |
Bollinger Bands (100): | (5.28 - 6.74) | Buy |
Trevi Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Trevi Therapeutics Stock
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 7.01 while TRVI 8-day simple moving average is 6.23, which is a Buy signal.
-
The stock price of TRVI is 7.01 while Trevi Therapeutics 20-day SMA is 6.01, which makes it a Buy.
-
Trevi Therapeutics 50-day simple moving average is 6.28 while TRVI share price is 7.01, making it a Buy technically.
-
TRVI stock price is 7.01 and Trevi Therapeutics 200-day simple moving average is 4.73, creating a Buy signal.
TRVI Technical Analysis vs Fundamental Analysis
Buy
52
Trevi Therapeutics (TRVI)
is a Buy
Is Trevi Therapeutics a Buy or a Sell?
-
Trevi Therapeutics stock is rated a BuyThe current Trevi Therapeutics [TRVI] share price is $7.01. The Score for TRVI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Trevi Therapeutics Stock Info
Market Cap:
713.2M
Price in USD:
7.01
Share Volume:
1.7M
Trevi Therapeutics 52-Week Range
52-Week High:
7.48
52-Week Low:
2.36
Buy
52
Trevi Therapeutics (TRVI)
is a Buy
Trevi Therapeutics Share Price Forecast
-
What is the Trevi Therapeutics stock price today?The Trevi Therapeutics stock price is 7.01 USD today.
-
Will TRVI stock go up or go down?Trevi Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Trevi Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Trevi Therapeutics is not overvalued.
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 7.01 while TRVI 8-day exponential moving average is 4.67, which is a Buy signal.
-
The stock price of TRVI is 7.01 while Trevi Therapeutics 20-day EMA is 2.54, which makes it a Buy.
-
Trevi Therapeutics 50-day exponential moving average is 1.16 while TRVI share price is 7.01, making it a Buy technically.
-
TRVI stock price is 7.01 and Trevi Therapeutics 200-day simple moving average is 0.31, creating a Buy signal.
Fundamental Analysis of Trevi Therapeutics
Is Trevi Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.06 per share, and a decrease next year of $0.06 per share.
Technical Analysis of Trevi Therapeutics
Should I short Trevi Therapeutics stock?
-
TRVI Moving Average Covergence Divergence (MACD) indicator is 1.62, suggesting Trevi Therapeutics is a Buy
-
Trevi Therapeutics Relative Strength Index (RSI) is 68.07, which suggest Trevi Therapeutics is overbought
-
The Bollinger Bands (25) for Trevi Therapeutics is (5.7 - 6.5), which suggest Trevi Therapeutics is a Buy
-
The Bollinger Bands (100) for Trevi Therapeutics is (5.28 - 6.74), which suggest Trevi Therapeutics is a Buy
* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.